Question 1

Has Erin Reid, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $266,966 in general payments to Erin Reid, MD across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Erin Reid, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Erin Reid, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
ADC Therapeutics America, Inc.	15	$144,936
Takeda Pharmaceuticals U.S.A., Inc.	22	$74,096
Epizyme, Inc.	15	$47,935

Drug	Claims	Cost to plans & patients
PomalystPomalidomide	21	$1,038,988
RevlimidLenalidomide	14	$232,530
ImbruvicaIbrutinib	13	$195,341
BrukinsaZanubrutinib	12	$169,244
Acyclovir	51	$1,768
Imiquimod	20	$870
Gabapentin	21	$324
Allopurinol	18	$114
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	17	$69
Prednisone	18	$34

Erin Reid, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in San Diego